Global Drugs for Schistosomiasis Supply, Demand and Key Producers, 2024-2030

Global Drugs for Schistosomiasis Supply, Demand and Key Producers, 2024-2030

Page: 103

Published Date: 10 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Drugs for Schistosomiasis market size is expected to reach $ 108.3 million by 2030, rising at a market growth of 3.6% CAGR during the forecast period (2024-2030).

Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.

East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

This report studies the global Drugs for Schistosomiasis production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Drugs for Schistosomiasis, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs for Schistosomiasis that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Drugs for Schistosomiasis total production and demand, 2019-2030, (M Units)
Global Drugs for Schistosomiasis total production value, 2019-2030, (USD Million)
Global Drugs for Schistosomiasis production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global Drugs for Schistosomiasis consumption by region & country, CAGR, 2019-2030 & (M Units)
U.S. VS China: Drugs for Schistosomiasis domestic production, consumption, key domestic manufacturers and share
Global Drugs for Schistosomiasis production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (M Units)
Global Drugs for Schistosomiasis production by Type, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global Drugs for Schistosomiasis production by Application production, value, CAGR, 2019-2030, (USD Million) & (M Units).

This reports profiles key players in the global Drugs for Schistosomiasis market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drugs for Schistosomiasis market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (USD/K Units) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Drugs for Schistosomiasis Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Drugs for Schistosomiasis Market, Segmentation by Type
Praziquantel
Oxamniquine
Other

Global Drugs for Schistosomiasis Market, Segmentation by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum

Companies Profiled:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals

Key Questions Answered
1. How big is the global Drugs for Schistosomiasis market?
2. What is the demand of the global Drugs for Schistosomiasis market?
3. What is the year over year growth of the global Drugs for Schistosomiasis market?
4. What is the production and production value of the global Drugs for Schistosomiasis market?
5. Who are the key producers in the global Drugs for Schistosomiasis market?
btl

Table of Contents

1 Supply Summary
1.1 Drugs for Schistosomiasis Introduction
1.2 World Drugs for Schistosomiasis Supply & Forecast
1.2.1 World Drugs for Schistosomiasis Production Value (2019 & 2023 & 2030)
1.2.2 World Drugs for Schistosomiasis Production (2019-2030)
1.2.3 World Drugs for Schistosomiasis Pricing Trends (2019-2030)
1.3 World Drugs for Schistosomiasis Production by Region (Based on Production Site)
1.3.1 World Drugs for Schistosomiasis Production Value by Region (2019-2030)
1.3.2 World Drugs for Schistosomiasis Production by Region (2019-2030)
1.3.3 World Drugs for Schistosomiasis Average Price by Region (2019-2030)
1.3.4 North America Drugs for Schistosomiasis Production (2019-2030)
1.3.5 Europe Drugs for Schistosomiasis Production (2019-2030)
1.3.6 China Drugs for Schistosomiasis Production (2019-2030)
1.3.7 Japan Drugs for Schistosomiasis Production (2019-2030)
1.3.8 India Drugs for Schistosomiasis Production (2019-2030)
1.3.9 South Korea Drugs for Schistosomiasis Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drugs for Schistosomiasis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drugs for Schistosomiasis Major Market Trends

2 Demand Summary
2.1 World Drugs for Schistosomiasis Demand (2019-2030)
2.2 World Drugs for Schistosomiasis Consumption by Region
2.2.1 World Drugs for Schistosomiasis Consumption by Region (2019-2024)
2.2.2 World Drugs for Schistosomiasis Consumption Forecast by Region (2025-2030)
2.3 United States Drugs for Schistosomiasis Consumption (2019-2030)
2.4 China Drugs for Schistosomiasis Consumption (2019-2030)
2.5 Europe Drugs for Schistosomiasis Consumption (2019-2030)
2.6 Japan Drugs for Schistosomiasis Consumption (2019-2030)
2.7 South Korea Drugs for Schistosomiasis Consumption (2019-2030)
2.8 ASEAN Drugs for Schistosomiasis Consumption (2019-2030)
2.9 India Drugs for Schistosomiasis Consumption (2019-2030)

3 World Drugs for Schistosomiasis Manufacturers Competitive Analysis
3.1 World Drugs for Schistosomiasis Production Value by Manufacturer (2019-2024)
3.2 World Drugs for Schistosomiasis Production by Manufacturer (2019-2024)
3.3 World Drugs for Schistosomiasis Average Price by Manufacturer (2019-2024)
3.4 Drugs for Schistosomiasis Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drugs for Schistosomiasis Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drugs for Schistosomiasis in 2023
3.5.3 Global Concentration Ratios (CR8) for Drugs for Schistosomiasis in 2023
3.6 Drugs for Schistosomiasis Market: Overall Company Footprint Analysis
3.6.1 Drugs for Schistosomiasis Market: Region Footprint
3.6.2 Drugs for Schistosomiasis Market: Company Product Type Footprint
3.6.3 Drugs for Schistosomiasis Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Drugs for Schistosomiasis Production Value Comparison
4.1.1 United States VS China: Drugs for Schistosomiasis Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Drugs for Schistosomiasis Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Drugs for Schistosomiasis Production Comparison
4.2.1 United States VS China: Drugs for Schistosomiasis Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Drugs for Schistosomiasis Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Drugs for Schistosomiasis Consumption Comparison
4.3.1 United States VS China: Drugs for Schistosomiasis Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Drugs for Schistosomiasis Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Drugs for Schistosomiasis Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Drugs for Schistosomiasis Production Value (2019-2024)
4.4.3 United States Based Manufacturers Drugs for Schistosomiasis Production (2019-2024)
4.5 China Based Drugs for Schistosomiasis Manufacturers and Market Share
4.5.1 China Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Drugs for Schistosomiasis Production Value (2019-2024)
4.5.3 China Based Manufacturers Drugs for Schistosomiasis Production (2019-2024)
4.6 Rest of World Based Drugs for Schistosomiasis Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Drugs for Schistosomiasis Production (2019-2024)

5 Market Analysis by Type
5.1 World Drugs for Schistosomiasis Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Praziquantel
5.2.2 Oxamniquine
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Drugs for Schistosomiasis Production by Type (2019-2030)
5.3.2 World Drugs for Schistosomiasis Production Value by Type (2019-2030)
5.3.3 World Drugs for Schistosomiasis Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Drugs for Schistosomiasis Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 S. haematobium
6.2.2 S. mansoni
6.2.3 S. japonicum
6.2.4 S. mekongi
6.2.5 S. intercalatum
6.3 Market Segment by Application
6.3.1 World Drugs for Schistosomiasis Production by Application (2019-2030)
6.3.2 World Drugs for Schistosomiasis Production Value by Application (2019-2030)
6.3.3 World Drugs for Schistosomiasis Average Price by Application (2019-2030)

7 Company Profiles
7.1 Shin Poong
7.1.1 Shin Poong Details
7.1.2 Shin Poong Major Business
7.1.3 Shin Poong Drugs for Schistosomiasis Product and Services
7.1.4 Shin Poong Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Shin Poong Recent Developments/Updates
7.1.6 Shin Poong Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Drugs for Schistosomiasis Product and Services
7.2.4 Merck Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Bayer
7.3.1 Bayer Details
7.3.2 Bayer Major Business
7.3.3 Bayer Drugs for Schistosomiasis Product and Services
7.3.4 Bayer Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bayer Recent Developments/Updates
7.3.6 Bayer Competitive Strengths & Weaknesses
7.4 EIPICO
7.4.1 EIPICO Details
7.4.2 EIPICO Major Business
7.4.3 EIPICO Drugs for Schistosomiasis Product and Services
7.4.4 EIPICO Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 EIPICO Recent Developments/Updates
7.4.6 EIPICO Competitive Strengths & Weaknesses
7.5 Chandra Bhagat Pharma
7.5.1 Chandra Bhagat Pharma Details
7.5.2 Chandra Bhagat Pharma Major Business
7.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
7.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Chandra Bhagat Pharma Recent Developments/Updates
7.5.6 Chandra Bhagat Pharma Competitive Strengths & Weaknesses
7.6 Taj Pharmaceuticals
7.6.1 Taj Pharmaceuticals Details
7.6.2 Taj Pharmaceuticals Major Business
7.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
7.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Taj Pharmaceuticals Recent Developments/Updates
7.6.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Drugs for Schistosomiasis Industry Chain
8.2 Drugs for Schistosomiasis Upstream Analysis
8.2.1 Drugs for Schistosomiasis Core Raw Materials
8.2.2 Main Manufacturers of Drugs for Schistosomiasis Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Drugs for Schistosomiasis Production Mode
8.6 Drugs for Schistosomiasis Procurement Model
8.7 Drugs for Schistosomiasis Industry Sales Model and Sales Channels
8.7.1 Drugs for Schistosomiasis Sales Model
8.7.2 Drugs for Schistosomiasis Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Drugs for Schistosomiasis Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Drugs for Schistosomiasis Production Value by Region (2019-2024) & (USD Million)
Table 3. World Drugs for Schistosomiasis Production Value by Region (2025-2030) & (USD Million)
Table 4. World Drugs for Schistosomiasis Production Value Market Share by Region (2019-2024)
Table 5. World Drugs for Schistosomiasis Production Value Market Share by Region (2025-2030)
Table 6. World Drugs for Schistosomiasis Production by Region (2019-2024) & (M Units)
Table 7. World Drugs for Schistosomiasis Production by Region (2025-2030) & (M Units)
Table 8. World Drugs for Schistosomiasis Production Market Share by Region (2019-2024)
Table 9. World Drugs for Schistosomiasis Production Market Share by Region (2025-2030)
Table 10. World Drugs for Schistosomiasis Average Price by Region (2019-2024) & (USD/K Units)
Table 11. World Drugs for Schistosomiasis Average Price by Region (2025-2030) & (USD/K Units)
Table 12. Drugs for Schistosomiasis Major Market Trends
Table 13. World Drugs for Schistosomiasis Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (M Units)
Table 14. World Drugs for Schistosomiasis Consumption by Region (2019-2024) & (M Units)
Table 15. World Drugs for Schistosomiasis Consumption Forecast by Region (2025-2030) & (M Units)
Table 16. World Drugs for Schistosomiasis Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Drugs for Schistosomiasis Producers in 2023
Table 18. World Drugs for Schistosomiasis Production by Manufacturer (2019-2024) & (M Units)
Table 19. Production Market Share of Key Drugs for Schistosomiasis Producers in 2023
Table 20. World Drugs for Schistosomiasis Average Price by Manufacturer (2019-2024) & (USD/K Units)
Table 21. Global Drugs for Schistosomiasis Company Evaluation Quadrant
Table 22. World Drugs for Schistosomiasis Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Drugs for Schistosomiasis Production Site of Key Manufacturer
Table 24. Drugs for Schistosomiasis Market: Company Product Type Footprint
Table 25. Drugs for Schistosomiasis Market: Company Product Application Footprint
Table 26. Drugs for Schistosomiasis Competitive Factors
Table 27. Drugs for Schistosomiasis New Entrant and Capacity Expansion Plans
Table 28. Drugs for Schistosomiasis Mergers & Acquisitions Activity
Table 29. United States VS China Drugs for Schistosomiasis Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Drugs for Schistosomiasis Production Comparison, (2019 & 2023 & 2030) & (M Units)
Table 31. United States VS China Drugs for Schistosomiasis Consumption Comparison, (2019 & 2023 & 2030) & (M Units)
Table 32. United States Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Drugs for Schistosomiasis Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Drugs for Schistosomiasis Production (2019-2024) & (M Units)
Table 36. United States Based Manufacturers Drugs for Schistosomiasis Production Market Share (2019-2024)
Table 37. China Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Drugs for Schistosomiasis Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Drugs for Schistosomiasis Production (2019-2024) & (M Units)
Table 41. China Based Manufacturers Drugs for Schistosomiasis Production Market Share (2019-2024)
Table 42. Rest of World Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Drugs for Schistosomiasis Production (2019-2024) & (M Units)
Table 46. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Market Share (2019-2024)
Table 47. World Drugs for Schistosomiasis Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Drugs for Schistosomiasis Production by Type (2019-2024) & (M Units)
Table 49. World Drugs for Schistosomiasis Production by Type (2025-2030) & (M Units)
Table 50. World Drugs for Schistosomiasis Production Value by Type (2019-2024) & (USD Million)
Table 51. World Drugs for Schistosomiasis Production Value by Type (2025-2030) & (USD Million)
Table 52. World Drugs for Schistosomiasis Average Price by Type (2019-2024) & (USD/K Units)
Table 53. World Drugs for Schistosomiasis Average Price by Type (2025-2030) & (USD/K Units)
Table 54. World Drugs for Schistosomiasis Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Drugs for Schistosomiasis Production by Application (2019-2024) & (M Units)
Table 56. World Drugs for Schistosomiasis Production by Application (2025-2030) & (M Units)
Table 57. World Drugs for Schistosomiasis Production Value by Application (2019-2024) & (USD Million)
Table 58. World Drugs for Schistosomiasis Production Value by Application (2025-2030) & (USD Million)
Table 59. World Drugs for Schistosomiasis Average Price by Application (2019-2024) & (USD/K Units)
Table 60. World Drugs for Schistosomiasis Average Price by Application (2025-2030) & (USD/K Units)
Table 61. Shin Poong Basic Information, Manufacturing Base and Competitors
Table 62. Shin Poong Major Business
Table 63. Shin Poong Drugs for Schistosomiasis Product and Services
Table 64. Shin Poong Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Shin Poong Recent Developments/Updates
Table 66. Shin Poong Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Drugs for Schistosomiasis Product and Services
Table 70. Merck Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Drugs for Schistosomiasis Product and Services
Table 76. Bayer Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Bayer Recent Developments/Updates
Table 78. Bayer Competitive Strengths & Weaknesses
Table 79. EIPICO Basic Information, Manufacturing Base and Competitors
Table 80. EIPICO Major Business
Table 81. EIPICO Drugs for Schistosomiasis Product and Services
Table 82. EIPICO Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. EIPICO Recent Developments/Updates
Table 84. EIPICO Competitive Strengths & Weaknesses
Table 85. Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Chandra Bhagat Pharma Major Business
Table 87. Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
Table 88. Chandra Bhagat Pharma Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Chandra Bhagat Pharma Recent Developments/Updates
Table 90. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 91. Taj Pharmaceuticals Major Business
Table 92. Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
Table 93. Taj Pharmaceuticals Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Drugs for Schistosomiasis Upstream (Raw Materials)
Table 95. Drugs for Schistosomiasis Typical Customers
Table 96. Drugs for Schistosomiasis Typical Distributors
List of Figure
Figure 1. Drugs for Schistosomiasis Picture
Figure 2. World Drugs for Schistosomiasis Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Drugs for Schistosomiasis Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 5. World Drugs for Schistosomiasis Average Price (2019-2030) & (USD/K Units)
Figure 6. World Drugs for Schistosomiasis Production Value Market Share by Region (2019-2030)
Figure 7. World Drugs for Schistosomiasis Production Market Share by Region (2019-2030)
Figure 8. North America Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 9. Europe Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 10. China Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 11. Japan Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 12. India Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 13. South Korea Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 14. Drugs for Schistosomiasis Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 17. World Drugs for Schistosomiasis Consumption Market Share by Region (2019-2030)
Figure 18. United States Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 19. China Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 20. Europe Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 21. Japan Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 22. South Korea Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 23. ASEAN Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 24. India Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 25. Producer Shipments of Drugs for Schistosomiasis by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 26. Global Four-firm Concentration Ratios (CR4) for Drugs for Schistosomiasis Markets in 2023
Figure 27. Global Four-firm Concentration Ratios (CR8) for Drugs for Schistosomiasis Markets in 2023
Figure 28. United States VS China: Drugs for Schistosomiasis Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: Drugs for Schistosomiasis Production Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States VS China: Drugs for Schistosomiasis Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 31. United States Based Manufacturers Drugs for Schistosomiasis Production Market Share 2023
Figure 32. China Based Manufacturers Drugs for Schistosomiasis Production Market Share 2023
Figure 33. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Market Share 2023
Figure 34. World Drugs for Schistosomiasis Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 35. World Drugs for Schistosomiasis Production Value Market Share by Type in 2023
Figure 36. Praziquantel
Figure 37. Oxamniquine
Figure 38. Other
Figure 39. World Drugs for Schistosomiasis Production Market Share by Type (2019-2030)
Figure 40. World Drugs for Schistosomiasis Production Value Market Share by Type (2019-2030)
Figure 41. World Drugs for Schistosomiasis Average Price by Type (2019-2030) & (USD/K Units)
Figure 42. World Drugs for Schistosomiasis Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World Drugs for Schistosomiasis Production Value Market Share by Application in 2023
Figure 44. S. haematobium
Figure 45. S. mansoni
Figure 46. S. japonicum
Figure 47. S. mekongi
Figure 48. S. intercalatum
Figure 49. World Drugs for Schistosomiasis Production Market Share by Application (2019-2030)
Figure 50. World Drugs for Schistosomiasis Production Value Market Share by Application (2019-2030)
Figure 51. World Drugs for Schistosomiasis Average Price by Application (2019-2030) & (USD/K Units)
Figure 52. Drugs for Schistosomiasis Industry Chain
Figure 53. Drugs for Schistosomiasis Procurement Model
Figure 54. Drugs for Schistosomiasis Sales Model
Figure 55. Drugs for Schistosomiasis Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Drugs for Schistosomiasis Supply, Demand and Key Producers, 2024-2030

Global Drugs for Schistosomiasis Supply, Demand and Key Producers, 2024-2030

Page: 103

Published Date: 10 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Drugs for Schistosomiasis market size is expected to reach $ 108.3 million by 2030, rising at a market growth of 3.6% CAGR during the forecast period (2024-2030).

Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.

East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

This report studies the global Drugs for Schistosomiasis production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Drugs for Schistosomiasis, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs for Schistosomiasis that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Drugs for Schistosomiasis total production and demand, 2019-2030, (M Units)
Global Drugs for Schistosomiasis total production value, 2019-2030, (USD Million)
Global Drugs for Schistosomiasis production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global Drugs for Schistosomiasis consumption by region & country, CAGR, 2019-2030 & (M Units)
U.S. VS China: Drugs for Schistosomiasis domestic production, consumption, key domestic manufacturers and share
Global Drugs for Schistosomiasis production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (M Units)
Global Drugs for Schistosomiasis production by Type, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global Drugs for Schistosomiasis production by Application production, value, CAGR, 2019-2030, (USD Million) & (M Units).

This reports profiles key players in the global Drugs for Schistosomiasis market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drugs for Schistosomiasis market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (USD/K Units) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Drugs for Schistosomiasis Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Drugs for Schistosomiasis Market, Segmentation by Type
Praziquantel
Oxamniquine
Other

Global Drugs for Schistosomiasis Market, Segmentation by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum

Companies Profiled:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals

Key Questions Answered
1. How big is the global Drugs for Schistosomiasis market?
2. What is the demand of the global Drugs for Schistosomiasis market?
3. What is the year over year growth of the global Drugs for Schistosomiasis market?
4. What is the production and production value of the global Drugs for Schistosomiasis market?
5. Who are the key producers in the global Drugs for Schistosomiasis market?
btl

Table of Contents

1 Supply Summary
1.1 Drugs for Schistosomiasis Introduction
1.2 World Drugs for Schistosomiasis Supply & Forecast
1.2.1 World Drugs for Schistosomiasis Production Value (2019 & 2023 & 2030)
1.2.2 World Drugs for Schistosomiasis Production (2019-2030)
1.2.3 World Drugs for Schistosomiasis Pricing Trends (2019-2030)
1.3 World Drugs for Schistosomiasis Production by Region (Based on Production Site)
1.3.1 World Drugs for Schistosomiasis Production Value by Region (2019-2030)
1.3.2 World Drugs for Schistosomiasis Production by Region (2019-2030)
1.3.3 World Drugs for Schistosomiasis Average Price by Region (2019-2030)
1.3.4 North America Drugs for Schistosomiasis Production (2019-2030)
1.3.5 Europe Drugs for Schistosomiasis Production (2019-2030)
1.3.6 China Drugs for Schistosomiasis Production (2019-2030)
1.3.7 Japan Drugs for Schistosomiasis Production (2019-2030)
1.3.8 India Drugs for Schistosomiasis Production (2019-2030)
1.3.9 South Korea Drugs for Schistosomiasis Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drugs for Schistosomiasis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drugs for Schistosomiasis Major Market Trends

2 Demand Summary
2.1 World Drugs for Schistosomiasis Demand (2019-2030)
2.2 World Drugs for Schistosomiasis Consumption by Region
2.2.1 World Drugs for Schistosomiasis Consumption by Region (2019-2024)
2.2.2 World Drugs for Schistosomiasis Consumption Forecast by Region (2025-2030)
2.3 United States Drugs for Schistosomiasis Consumption (2019-2030)
2.4 China Drugs for Schistosomiasis Consumption (2019-2030)
2.5 Europe Drugs for Schistosomiasis Consumption (2019-2030)
2.6 Japan Drugs for Schistosomiasis Consumption (2019-2030)
2.7 South Korea Drugs for Schistosomiasis Consumption (2019-2030)
2.8 ASEAN Drugs for Schistosomiasis Consumption (2019-2030)
2.9 India Drugs for Schistosomiasis Consumption (2019-2030)

3 World Drugs for Schistosomiasis Manufacturers Competitive Analysis
3.1 World Drugs for Schistosomiasis Production Value by Manufacturer (2019-2024)
3.2 World Drugs for Schistosomiasis Production by Manufacturer (2019-2024)
3.3 World Drugs for Schistosomiasis Average Price by Manufacturer (2019-2024)
3.4 Drugs for Schistosomiasis Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drugs for Schistosomiasis Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drugs for Schistosomiasis in 2023
3.5.3 Global Concentration Ratios (CR8) for Drugs for Schistosomiasis in 2023
3.6 Drugs for Schistosomiasis Market: Overall Company Footprint Analysis
3.6.1 Drugs for Schistosomiasis Market: Region Footprint
3.6.2 Drugs for Schistosomiasis Market: Company Product Type Footprint
3.6.3 Drugs for Schistosomiasis Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Drugs for Schistosomiasis Production Value Comparison
4.1.1 United States VS China: Drugs for Schistosomiasis Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Drugs for Schistosomiasis Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Drugs for Schistosomiasis Production Comparison
4.2.1 United States VS China: Drugs for Schistosomiasis Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Drugs for Schistosomiasis Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Drugs for Schistosomiasis Consumption Comparison
4.3.1 United States VS China: Drugs for Schistosomiasis Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Drugs for Schistosomiasis Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Drugs for Schistosomiasis Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Drugs for Schistosomiasis Production Value (2019-2024)
4.4.3 United States Based Manufacturers Drugs for Schistosomiasis Production (2019-2024)
4.5 China Based Drugs for Schistosomiasis Manufacturers and Market Share
4.5.1 China Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Drugs for Schistosomiasis Production Value (2019-2024)
4.5.3 China Based Manufacturers Drugs for Schistosomiasis Production (2019-2024)
4.6 Rest of World Based Drugs for Schistosomiasis Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Drugs for Schistosomiasis Production (2019-2024)

5 Market Analysis by Type
5.1 World Drugs for Schistosomiasis Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Praziquantel
5.2.2 Oxamniquine
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Drugs for Schistosomiasis Production by Type (2019-2030)
5.3.2 World Drugs for Schistosomiasis Production Value by Type (2019-2030)
5.3.3 World Drugs for Schistosomiasis Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Drugs for Schistosomiasis Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 S. haematobium
6.2.2 S. mansoni
6.2.3 S. japonicum
6.2.4 S. mekongi
6.2.5 S. intercalatum
6.3 Market Segment by Application
6.3.1 World Drugs for Schistosomiasis Production by Application (2019-2030)
6.3.2 World Drugs for Schistosomiasis Production Value by Application (2019-2030)
6.3.3 World Drugs for Schistosomiasis Average Price by Application (2019-2030)

7 Company Profiles
7.1 Shin Poong
7.1.1 Shin Poong Details
7.1.2 Shin Poong Major Business
7.1.3 Shin Poong Drugs for Schistosomiasis Product and Services
7.1.4 Shin Poong Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Shin Poong Recent Developments/Updates
7.1.6 Shin Poong Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Drugs for Schistosomiasis Product and Services
7.2.4 Merck Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Bayer
7.3.1 Bayer Details
7.3.2 Bayer Major Business
7.3.3 Bayer Drugs for Schistosomiasis Product and Services
7.3.4 Bayer Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bayer Recent Developments/Updates
7.3.6 Bayer Competitive Strengths & Weaknesses
7.4 EIPICO
7.4.1 EIPICO Details
7.4.2 EIPICO Major Business
7.4.3 EIPICO Drugs for Schistosomiasis Product and Services
7.4.4 EIPICO Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 EIPICO Recent Developments/Updates
7.4.6 EIPICO Competitive Strengths & Weaknesses
7.5 Chandra Bhagat Pharma
7.5.1 Chandra Bhagat Pharma Details
7.5.2 Chandra Bhagat Pharma Major Business
7.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
7.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Chandra Bhagat Pharma Recent Developments/Updates
7.5.6 Chandra Bhagat Pharma Competitive Strengths & Weaknesses
7.6 Taj Pharmaceuticals
7.6.1 Taj Pharmaceuticals Details
7.6.2 Taj Pharmaceuticals Major Business
7.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
7.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Taj Pharmaceuticals Recent Developments/Updates
7.6.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Drugs for Schistosomiasis Industry Chain
8.2 Drugs for Schistosomiasis Upstream Analysis
8.2.1 Drugs for Schistosomiasis Core Raw Materials
8.2.2 Main Manufacturers of Drugs for Schistosomiasis Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Drugs for Schistosomiasis Production Mode
8.6 Drugs for Schistosomiasis Procurement Model
8.7 Drugs for Schistosomiasis Industry Sales Model and Sales Channels
8.7.1 Drugs for Schistosomiasis Sales Model
8.7.2 Drugs for Schistosomiasis Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Drugs for Schistosomiasis Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Drugs for Schistosomiasis Production Value by Region (2019-2024) & (USD Million)
Table 3. World Drugs for Schistosomiasis Production Value by Region (2025-2030) & (USD Million)
Table 4. World Drugs for Schistosomiasis Production Value Market Share by Region (2019-2024)
Table 5. World Drugs for Schistosomiasis Production Value Market Share by Region (2025-2030)
Table 6. World Drugs for Schistosomiasis Production by Region (2019-2024) & (M Units)
Table 7. World Drugs for Schistosomiasis Production by Region (2025-2030) & (M Units)
Table 8. World Drugs for Schistosomiasis Production Market Share by Region (2019-2024)
Table 9. World Drugs for Schistosomiasis Production Market Share by Region (2025-2030)
Table 10. World Drugs for Schistosomiasis Average Price by Region (2019-2024) & (USD/K Units)
Table 11. World Drugs for Schistosomiasis Average Price by Region (2025-2030) & (USD/K Units)
Table 12. Drugs for Schistosomiasis Major Market Trends
Table 13. World Drugs for Schistosomiasis Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (M Units)
Table 14. World Drugs for Schistosomiasis Consumption by Region (2019-2024) & (M Units)
Table 15. World Drugs for Schistosomiasis Consumption Forecast by Region (2025-2030) & (M Units)
Table 16. World Drugs for Schistosomiasis Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Drugs for Schistosomiasis Producers in 2023
Table 18. World Drugs for Schistosomiasis Production by Manufacturer (2019-2024) & (M Units)
Table 19. Production Market Share of Key Drugs for Schistosomiasis Producers in 2023
Table 20. World Drugs for Schistosomiasis Average Price by Manufacturer (2019-2024) & (USD/K Units)
Table 21. Global Drugs for Schistosomiasis Company Evaluation Quadrant
Table 22. World Drugs for Schistosomiasis Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Drugs for Schistosomiasis Production Site of Key Manufacturer
Table 24. Drugs for Schistosomiasis Market: Company Product Type Footprint
Table 25. Drugs for Schistosomiasis Market: Company Product Application Footprint
Table 26. Drugs for Schistosomiasis Competitive Factors
Table 27. Drugs for Schistosomiasis New Entrant and Capacity Expansion Plans
Table 28. Drugs for Schistosomiasis Mergers & Acquisitions Activity
Table 29. United States VS China Drugs for Schistosomiasis Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Drugs for Schistosomiasis Production Comparison, (2019 & 2023 & 2030) & (M Units)
Table 31. United States VS China Drugs for Schistosomiasis Consumption Comparison, (2019 & 2023 & 2030) & (M Units)
Table 32. United States Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Drugs for Schistosomiasis Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Drugs for Schistosomiasis Production (2019-2024) & (M Units)
Table 36. United States Based Manufacturers Drugs for Schistosomiasis Production Market Share (2019-2024)
Table 37. China Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Drugs for Schistosomiasis Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Drugs for Schistosomiasis Production (2019-2024) & (M Units)
Table 41. China Based Manufacturers Drugs for Schistosomiasis Production Market Share (2019-2024)
Table 42. Rest of World Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Drugs for Schistosomiasis Production (2019-2024) & (M Units)
Table 46. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Market Share (2019-2024)
Table 47. World Drugs for Schistosomiasis Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Drugs for Schistosomiasis Production by Type (2019-2024) & (M Units)
Table 49. World Drugs for Schistosomiasis Production by Type (2025-2030) & (M Units)
Table 50. World Drugs for Schistosomiasis Production Value by Type (2019-2024) & (USD Million)
Table 51. World Drugs for Schistosomiasis Production Value by Type (2025-2030) & (USD Million)
Table 52. World Drugs for Schistosomiasis Average Price by Type (2019-2024) & (USD/K Units)
Table 53. World Drugs for Schistosomiasis Average Price by Type (2025-2030) & (USD/K Units)
Table 54. World Drugs for Schistosomiasis Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Drugs for Schistosomiasis Production by Application (2019-2024) & (M Units)
Table 56. World Drugs for Schistosomiasis Production by Application (2025-2030) & (M Units)
Table 57. World Drugs for Schistosomiasis Production Value by Application (2019-2024) & (USD Million)
Table 58. World Drugs for Schistosomiasis Production Value by Application (2025-2030) & (USD Million)
Table 59. World Drugs for Schistosomiasis Average Price by Application (2019-2024) & (USD/K Units)
Table 60. World Drugs for Schistosomiasis Average Price by Application (2025-2030) & (USD/K Units)
Table 61. Shin Poong Basic Information, Manufacturing Base and Competitors
Table 62. Shin Poong Major Business
Table 63. Shin Poong Drugs for Schistosomiasis Product and Services
Table 64. Shin Poong Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Shin Poong Recent Developments/Updates
Table 66. Shin Poong Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Drugs for Schistosomiasis Product and Services
Table 70. Merck Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Drugs for Schistosomiasis Product and Services
Table 76. Bayer Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Bayer Recent Developments/Updates
Table 78. Bayer Competitive Strengths & Weaknesses
Table 79. EIPICO Basic Information, Manufacturing Base and Competitors
Table 80. EIPICO Major Business
Table 81. EIPICO Drugs for Schistosomiasis Product and Services
Table 82. EIPICO Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. EIPICO Recent Developments/Updates
Table 84. EIPICO Competitive Strengths & Weaknesses
Table 85. Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Chandra Bhagat Pharma Major Business
Table 87. Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
Table 88. Chandra Bhagat Pharma Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Chandra Bhagat Pharma Recent Developments/Updates
Table 90. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 91. Taj Pharmaceuticals Major Business
Table 92. Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
Table 93. Taj Pharmaceuticals Drugs for Schistosomiasis Production (M Units), Price (USD/K Units), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Drugs for Schistosomiasis Upstream (Raw Materials)
Table 95. Drugs for Schistosomiasis Typical Customers
Table 96. Drugs for Schistosomiasis Typical Distributors
List of Figure
Figure 1. Drugs for Schistosomiasis Picture
Figure 2. World Drugs for Schistosomiasis Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Drugs for Schistosomiasis Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 5. World Drugs for Schistosomiasis Average Price (2019-2030) & (USD/K Units)
Figure 6. World Drugs for Schistosomiasis Production Value Market Share by Region (2019-2030)
Figure 7. World Drugs for Schistosomiasis Production Market Share by Region (2019-2030)
Figure 8. North America Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 9. Europe Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 10. China Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 11. Japan Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 12. India Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 13. South Korea Drugs for Schistosomiasis Production (2019-2030) & (M Units)
Figure 14. Drugs for Schistosomiasis Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 17. World Drugs for Schistosomiasis Consumption Market Share by Region (2019-2030)
Figure 18. United States Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 19. China Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 20. Europe Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 21. Japan Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 22. South Korea Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 23. ASEAN Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 24. India Drugs for Schistosomiasis Consumption (2019-2030) & (M Units)
Figure 25. Producer Shipments of Drugs for Schistosomiasis by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 26. Global Four-firm Concentration Ratios (CR4) for Drugs for Schistosomiasis Markets in 2023
Figure 27. Global Four-firm Concentration Ratios (CR8) for Drugs for Schistosomiasis Markets in 2023
Figure 28. United States VS China: Drugs for Schistosomiasis Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: Drugs for Schistosomiasis Production Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States VS China: Drugs for Schistosomiasis Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 31. United States Based Manufacturers Drugs for Schistosomiasis Production Market Share 2023
Figure 32. China Based Manufacturers Drugs for Schistosomiasis Production Market Share 2023
Figure 33. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Market Share 2023
Figure 34. World Drugs for Schistosomiasis Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 35. World Drugs for Schistosomiasis Production Value Market Share by Type in 2023
Figure 36. Praziquantel
Figure 37. Oxamniquine
Figure 38. Other
Figure 39. World Drugs for Schistosomiasis Production Market Share by Type (2019-2030)
Figure 40. World Drugs for Schistosomiasis Production Value Market Share by Type (2019-2030)
Figure 41. World Drugs for Schistosomiasis Average Price by Type (2019-2030) & (USD/K Units)
Figure 42. World Drugs for Schistosomiasis Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World Drugs for Schistosomiasis Production Value Market Share by Application in 2023
Figure 44. S. haematobium
Figure 45. S. mansoni
Figure 46. S. japonicum
Figure 47. S. mekongi
Figure 48. S. intercalatum
Figure 49. World Drugs for Schistosomiasis Production Market Share by Application (2019-2030)
Figure 50. World Drugs for Schistosomiasis Production Value Market Share by Application (2019-2030)
Figure 51. World Drugs for Schistosomiasis Average Price by Application (2019-2030) & (USD/K Units)
Figure 52. Drugs for Schistosomiasis Industry Chain
Figure 53. Drugs for Schistosomiasis Procurement Model
Figure 54. Drugs for Schistosomiasis Sales Model
Figure 55. Drugs for Schistosomiasis Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now